Skip to main contentSkip to navigation
Sirius Investors
Poseida Therapeutics, Inc.

Poseida Therapeutics, Inc.

PSTX
NASDAQHealthcare

Revenue Analysis - PSTX

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

PSTX Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

Collaboration Revenue

0.0% of total revenue

$71.7M

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 6 records)

Date
Collaboration Revenue
9/30/2024$71.7M
6/30/2024$26.0M
3/31/2024$28.1M
12/31/2023$34.3M
9/30/2023$9.4M

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Growing Segments
Collaboration Revenue+176.2%

Geographic Regions

Insufficient data for trend analysis

Earnings Reports

Want to see how PSTX's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports